Human Orthoreovirus Type 3 Dearing is not pathogenic to humans and has been evaluated clinically as an oncolytic agent. Its transduction efficiency and the tumor cell selectivity may be enhanced by incorporating ligands for alternative receptors. However, the genetic modification of reoviruses has been difficult, and genetic targeting of reoviruses has not been reported so far. Here we describe a technique for generating genetically targeted reoviruses. The propagation of wild-type reoviruses on cells expressing a modified s1-encoding segment embedded in a conventional RNA polymerase II transcript leads to substitution of the wild-type genome segment by the modified version. This technique was used for generating reoviruses that are genetically targeted to an artificial receptor expressed on U118MG cells. These cells lack the junction adhesion molecule-1 and therefore resist infection by wild-type reoviruses. The targeted reoviruses were engineered to carry the ligand for this receptor at the C terminus of the s1 spike protein. This demonstrates that the C terminus of the s1 protein is a suitable locale for the insertion of oligopeptide ligands and that targeting of reoviruses is feasible. The genetically targeted viruses can be propagated using the modified U118MG cells as helper cells. This technique may be applicable for the improvement of human reoviruses as oncolytic agents.
Introduction
Orthoreovirus Type 3 Dearing (T3D) has been evaluated clinically as an oncolytic agent. 1, 2 The impetus for these studies has been the observation that reovirus T3D preferentially lyses tumor cells, especially those with an activated Ras signaling pathway. [3] [4] [5] [6] [7] The Reoviridae (Respiratory Enteric Orphan viruses) constitute a family of non-enveloped viruses with segmented double-strand (ds) RNA genomes. The three types of human reoviruses have 10 genome segments and are classified in the genus Orthoreovirus. These viruses are not associated with disease in humans. In newborn mice, however, these viruses can cause lethal infections. 8 T3D is often studied and serves as a model for the family. Reovirus T3D enters the host cell through the interaction of the spike protein s1 with its cognate receptor, the junction adhesion molecule (JAM-1). In addition, sialic acid groups at the cell surface can act as receptors. [9] [10] [11] [12] [13] The JAM-1-binding amino acids are located in the C-terminal head domain of s1.
11, [14] [15] [16] After cell attachment, integrin-binding motifs in the capsid protein l2, which form the structural base for s1, bind b1 integrins and mediate endocytosis. 17 Following endosomal escape, viral replication ensues. Capped plus-strand RNA molecules are formed by transcription of the genome segments by the viral RNA-dependent RNA polymerase. Plus-strand RNA molecules are used for translation and also associate with viral core proteins in special virus-induced cellular compartments, the so-called 'viral factories'. 18 The packaging of the 10 genomic segments must be well orchestrated, as each viral core must contain a single copy of each of the plus-strand transcripts. Recent studies suggest that sequences contained within the 130 nucleotides (nt) at the 5 0 terminus serve as an identity label for each of the segments. 19 Negative-strand synthesis takes place within the newly formed core, yielding dsRNA segments. These can be further transcribed or included in maturing virions to be released by the infected cell. [20] [21] [22] The plus-strand RNAs contain the tetranucleotide sequence 'GCUA' at the 5 0 end and the pentanucleotide sequence 'UCAUC' at the 3 0 end, which may have a role in the encapsidation process. 23 The efficiency of reovirus-based oncolytic therapies is most likely compromised by the scarcity of reovirus receptors on the surface of tumor cells. Freshly isolated colorectal tumor cells resist T3D infection, probably due to a lack of JAM-1 on their surface. 24 The transduction efficiency and the tumor cell selectivity of oncolytic viruses, such as adenoviruses, have been enhanced by genetically incorporating ligands for alternative receptors. 25 However, genetic modification of reoviruses has been notoriously difficult. A few reports have been published on the genetic modification of members of the Reoviridae family. 21, 26 However, these systems are arduous and rather inefficient. Recently, a reverse genetics method has been described that relies on transfection of 10 different expression plasmids encoding all of the viral segments. 27 With this method, a heterologous transgene was engineered into one of the genome segments. However, the genetic modification of capsid components to amend viral tropism was not reported.
Here we describe a new technique for genetically modifying reoviruses. The technique was used for generating targeted T3D variants carrying (His) 6 tags at exposed positions in the head domain of the s1 spike. Reoviruses carrying the s1-(His) 6 spikes, but not wildtype T3D, can infect genetically engineered U118MG glioblastoma cells displaying a single-chain antibody fragment (scFv-His), recognizing the (His) 6 tag as an artificial receptor on their surface. The (His) 6 -tagged reoviruses, in combination with the scFv-His-expressing U118MG cells, can serve as a basis for developing tumortargeted reoviruses.
Results
The efficacy and specificity of oncolytic virus approaches can be enhanced by targeting infection to tumor cells. The development of targeted reoviruses has been hampered by the difficulties in applying reverse genetics procedures to the segmented dsRNA genomes of these viruses. Therefore, we set out to develop a novel technique for generating such genetically targeted reoviruses (Figure 1) . A cell line was selected that supports reovirus replication but resists infection due to the absence of reovirus receptors. This cell line was endowed with a cell-surface protein that can function as an artificial receptor. The codons for the peptide ligand were engineered in a suitable position in one of the reovirus capsid proteins. Finally, the genomic segment encoding this modified capsid protein was introduced into the reovirus genome.
JAM-1 deficiency underlies U118MG resistance
to reovirus infection A cell line lacking reovirus receptors and, as a result, resistant to infection is crucial in the development of genetically retargeted reoviruses. On the basis of published data, 28 the human glioblastoma cell line Figure 1 Schematic representation of the selection system for a targeted reovirus. The lentivirus vector LV-S1His was used to transfer a reovirus S1 expression cassette into 911 cells. The resulting 911S1His cells produce the s1 protein carrying the (His) 6 tag at its C terminus. On infection of the 911S1His cells with wild-type T3D, the progeny viruses may carry a mixture of s1-His and s1 spike proteins in their capsid. As a consequence, these viruses can infect the U118scFvHis cells that display an anti-His tag single-chain antibody on their cell surface, which can serve as an artificial receptor. Unmodified U118MG cells resist reovirus infection. Sequential passaging of virus in U118scFvHis cells selects for viruses in which the wild-type S1 segment has been replaced by the heterologous S1His segment during replication in the 911S1His cells.
Genetic targeting of reoviruses DJM van den Wollenberg et al U118MG was selected as a candidate. To confirm its resistance to reovirus infection, cultures of U118MG cells were exposed to T3D and assayed for cell viability (Figure 2a ). The viability of U118MG cells was not affected by T3D, up to a multiplicity of infection (MOI) of 100. In contrast, survival of the control cell line 911 declined significantly after infection at an MOI of 0.001. The viability of the cells, as measured by WST-1 assay, strongly correlated with the induction of cytopathic effect (CPE) (data not shown).
To determine whether the resistance of U118MG cells to T3D is due to the absence of the reovirus receptor JAM-1, 9, 29, 30 RNA isolated from U118MG cells and 911 cells was assayed for the presence of JAM-1 mRNA by reverse transcription-PCR (RT-PCR) using a JAM-1-specific primer set. The RNA from U118MG cells yielded no detectable PCR product (Figure 2b ), confirming the absence of JAM-1. This was further corroborated by immunofluorescence microscopy with JAM-1-specific antisera (data not shown). In contrast, JAM-1 mRNA was readily detectable in 911 cell-derived RNA (Figure 2b ).
To study whether the absence of JAM-1 is the sole factor contributing to the resistance of U118MG cells to T3D infection, U118MG cells were transduced with a lentiviral vector encoding hemagglutinin (HA)-tagged JAM-1 ( Figure 3 ). In another vector (LV-JAM-ECD), the extracellular domain (ECD) of JAM-1 was linked to a heterologous transmembrane domain to formally rule out JAM-1-mediated signaling (Figure 2c ). Parental U118MG cells and HA-JAM-or JAM-ECD-expressing U118MG cells were exposed to T3D and metabolically labeled with [ 35 S]-methionine to assess reovirus protein synthesis, as an indicator of viral replication. No synthesis of reovirus proteins was observed up to 7 days postinfection in U118MG. In contrast, synthesis of the reovirus proteins was detectable in the HA-JAM-and JAM-ECD-expressing U118MG derivatives (Figure 2d ). Note that host-protein synthesis is not fully shut off by reovirus in U118MG cells. Taken together, these data show that the absence of JAM-1 on the surface of U118MG is the only reason for its resistance to reovirus T3D.
Expression of an artificial receptor on the surface of U118MG cells
As an artificial receptor that could be utilized by targeted reoviruses, we exploited a single-chain antibody fragment specific for stretch of six C-terminal histidine residues (scFv-His) 31 as an artificial receptor for the reovirus T3D. This scFv is expressed on the surface of mammalian cells, if linked to a transmembrane domain, and has been previously used as an artificial receptor for Table 1 ). As a positive control (+), a small amount of the pCDNA-HA-JAM plasmid was included in a PCR (for product length, see Table 1 ). A b-actin-specific RT-PCR assay was performed to confirm the integrity of the RNA. Genetic targeting of reoviruses DJM van den Wollenberg et al the propagation of recombinant adenoviruses. 32 The codons for scFv-His, linked to the transmembrane domain of the human platelet-derived growth factor receptor and an HA tag, were inserted into the vector pLV-CMV-x-IRES-Neo (Figure 3) , and the resulting vector was used to transduce U118MG cells. Immunochemical staining confirmed homogeneous expression of the artificial receptor in the transduced U118MG cell population (data not shown).
Modification of s1 by adding a (His) 6 tag to its C terminus
To produce s1 variants, we opted to use a transcomplementation approach in which reovirus was propagated on a cell line producing one of the capsid components. The virus may incorporate the modified component in its capsid during virus generation. To generate reoviruses with modified s1 variants in its capsid, 911 cells were generated that stably express a modified S1 gene segment. The S1 genome segment was cloned from wild-type reovirus T3D-infected 911 cells, using primers chosen on the basis of the published S1 sequence. 33 The deduced s1 amino-acid sequence of the S1 genome segment cloned from the ATCC VR-824 T3D reovirus batch was found to differ from the published S1 sequence at two positions, Ile 246 to Thr and Thr 249 to Ile. These mutations are known to abolish a trypsin-sensitive site in the s1 shaft. 34 The codons for (His) 6 tag were inserted by mutation PCR downstream of the triplet encoding the C-terminal Thr of s1. The resulting recombinant S1 genome segment encoding (His) 6 -tagged s1 (S1His) was inserted into a lentiviral vector ( Figure 3 ). This vector was used to generate 911 cells, which stably express S1His. The synthesis of the (His) 6 Table 1 ) and western blot analysis (Figure 4d ). The staining pattern of s1-His (Figure 4a ) is reminiscent of the morphology of the viral factory. 8, 35 These data led us to conclude that s1-His protein was produced in the transduced cells.
Reovirus pseudotyping by modification of s-1
To evaluate whether the s1-His protein was incorporated in the capsid, the 911S1His cells were infected with wildtype T3D, and the virus was passaged three times on the 911S1His cells. If s1-His is incorporated, it could amend the tropism. To test the tropism, U118MG, U118HA-JAM and U118scFvHis cells were infected with either wildtype T3D or T3D from the third passage on 911S1His cells. T3D harvested from 911S1His cells, but not wildtype T3D virus, could infect and lyse U118scFvHis cells (Figure 5a ). The cell viability assay confirmed that U118MG cells resist the s1-His-containing T3D and 6 tag. S1His is a modified cDNA of the reovirus T3D S1 segment in which the (His) 6 tag is fused with s1. PDGF, plateletderived growth factor. Table 1 for the sequence of the primers). (c) RT-PCR to detect S1 RNA in 911S1His cells. Reverse transcription of 911S1His and 911 cell RNA was performed using primer S1endR. The plasmid pRT3S1His was used as a positive control for the PCR analysis that used the primers indicated in (b). The positions of the primers in the S1 segment, as well as the expected PCR products S1F-E and S1F-His, are indicated in (b). (d) Western analysis demonstrating the presence of the s1-His protein in 911S1His cell lysates. s1-His protein was detected with the Penta-His antibody. DAPI, 4 0 ,6-diamidino-2-phenylindole; FITC, fluorescein isothiocyanate; RT-PCR, reverse transcription-PCR.
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showed survival of 10% of the U118HA-JAM cells at 3 days after exposure to the 911S1His cell-derived T3D. U118scFvHis cells exposed to the s1-pseudotyped T3D showed a drop of 55% in viability (Figure 5b ). These data demonstrate that the 911S1His-derived reovirus can infect U118MG cells that express the scFvHis as an artificial receptor. From these results, we conclude that s1-His is incorporated in the reovirus capsid, that the (His) 6 tag is accessible to the artificial receptor and that interaction of this tag with its receptor leads to productive infection.
Selecting a genetically modified reovirus
Recent data suggest that the sequence motifs that facilitate assortment and packaging of the reovirus segments are contained within a 130 nt region at the 5 0 end of reoviral RNAs. 19 This region is also present in the heterologous transcripts produced in 911S1His cells. If the reoviral signals in the LV-S1His-derived s1-His-encoding transcripts are functional, these transcripts should associate with newly formed cores and replace the wild-type S1 segment in the progeny virus.
To test this hypothesis, we harvested the virus progeny from the U118scFvHis cells that were infected with s1-pseudotyped T3D. If the particles contain the S1His genome segment, it should be possible to propagate them on U118scFvHis cells. Indeed, a metabolic labeling experiment performed at 3 days postinfection showed that the reovirus particles produced in U118scFvHis cells could again infect U118scFvHis, in contrast to unmodified T3D (Figure 6a ). The propagated virus, which was named T3D-S1His, was passaged 11 times and maintained the s1-His protein as assayed by western blotting (Figure 6b ). The presence of the (His) 6 tag was also confirmed by sequence analysis of cloned RT-PCR products ( Figure 7 ). These data suggest that S1His segment is incorporated as a genome segment in T3D and expands its tropism.
Selection for the (His) 6 tag coselects other alterations in genome segment S1
So far we have demonstrated that the (His) 6 tag of the S1 segment is incorporated in the reovirus. To test whether selection for the presence of the (His) 6 tag could be used for selecting other mutations in the same segment, we repeated the selection experiment with the T3D laboratory strain R124. The nucleotide sequence of S1 from R124 differs in two nucleotides from that used to construct LV-S1His (Figure 7 ). This allows distinguishing the origin of the S1 sequences in the resulting T3D-S1His independent of the His tag sequences. After three passages of R124 on 911S1His cells, the virus was harvested and used to infect U118MG, U118HA-JAM and U118scFvHis cells. CPE was observed in U118HA-JAM and U118scFvHis cell cultures but not in the infected U118MG cultures. In contrast, non-pseudotyped R124 only induced cell death in U118HA-JAM cells (data not shown).
The virus produced in the U118scFvHis cells was passaged for six times on this cell line. The resulting virus, named R124-S1His, was used again to infect U118scFvHis cells. After confirming the presence of the (His) 6 -tagged s1 (Figure 8a) , RNA was isolated from infected cells and the S1 segments were cloned after RT-PCR amplification. Sequence analysis confirmed the presence of the (His) 6 tag-encoding sequence. All clones have a sequence identical to the cloned S1His, rather than the R124-S1, at the positions that differ between isolates (Figures 8b and c) . These data suggest that selection for the presence of the (His) 6 tag leads to incorporation of the entire S1 segment into reovirus particles. A few additional changes were found in the s1 encoded by the S1 of R124-S1His (Figure 7 ). This can be attributed to the RNA-dependent relative lack of fidelity of the RNA polymerase. 36 The fact that all the clones contained an S325Y mutation suggests that this mutation occurred early during passaging on U118scFvHis cells. Taken together, our data are consistent with a mechanism Genetic targeting of reoviruses DJM van den Wollenberg et al in which the entire S1 genome segment is replaced by the S1His segment.
Selective infection of cells in a mixed population by a targeted reovirus
To verify that genetically targeted reoviruses could be used to selectively eradicate specific cells in a mixed population, U118scFvHis cells were plated with U118-eGFP cells to represent target and non-target cells, respectively. A number of these mixed cultures were exposed to the R124-S1His virus at an MOI of 1. 
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Discussion
Reverse genetics in RNA viruses with segmented genomes has been technically challenging. For Reoviridae, this is due, at least in part, to the difficulties in achieving sufficient quantities of non-polyadenylated plus-strand reovirus RNAs in the cytoplasm of mammalian cells. The previously described methods to manipulate reovirus genomes either involve transfection of RNA synthesized in vitro or employ T7 polymerasedriven expression cassettes. 21, 26, 27 In these techniques, ribozymes generate transcripts with 3 0 ends, which are identical to normal segment termini. In general, such transcripts are unstable as they lack a poly-A tract. 21, 26, 27 Here we show that polyadenylated transcripts generated with a conventional RNA polymerase II expression cassette can also be used to replace a genome segment. A transcript containing a modified copy of the reovirus T3D S1 segment, encoding a (His) 6 -tagged version of the spike protein s1, was stably expressed. This protein was capable of binding a single-chain antibody fragment for oligo (His) tags. Propagation of wild-type T3D on cells producing s1-His led to its incorporation into reovirus capsids. A similar strategy has been previously used for other capsid proteins of reoviruses 37 and other nonenveloped viruses such as adenoviruses. 38, 39 However, if the genetic sequences encoding the modified capsid protein are not encapsidated, the altered targeting specificity would be lost after a single round of replication.
The transcripts encoded by the lentivirus vector LV-S1HIS contain all genetic information and most likely also the structural information contained within the S1 segment, for example the motifs regulating plus-and minus-strand synthesis. We hypothesized that these transcripts would be targeted to the 'viral factories' and here associate with newly formed viral cores. Furthermore, if the signals for minus-strand synthesis 22, 40 are functional, the S1 part of the lentiviral transcript should be converted in dsRNA. Secondary transcription of this dsRNA would lead to S1 segments with authentic termini. Our results propagating the T3D-S1His variant support these hypotheses.
On the basis of our hypothesis, we anticipated that the entire LV-S1His-derived genome segment, rather than only the region encoding the (His) 6 tag, would become incorporated into the virion. This was confirmed using the R124 strain in the selection. The reovirus selected after infection of the U118scFvHis with the R124 strain propagated in 911S1His cells contained the sequence of the (His) 6 -tagged s1-encoding segment instead of the S1 from R124 at the isolate-specific positions. These findings are consistent with the model that the entire S1His segment is derived from the transcript specified by LVS1His.
This approach may prove useful for improving reoviruses as oncolytic agents. To date, only wild-type T3D has been used in clinical trials. 1, 6, 41 The results of this approach are encouraging and the procedure is welltolerated. However, the scarcity or inaccessibility of reovirus receptors on the surface of tumor cells may limit the efficacy of wild-type reoviruses as oncolytic agents. We recently reported that cultures of colorectal tumor cells isolated from resected tumor material resist reovirus infection, despite the presence of JAM-1. 24 This is most likely attributable to the insufficient expression of reovirus receptors at their plasma membranes as T3D-derived infectious subviral particles, which are known to enter cells independent of JAM-1 and sialic acid, efficiently infect and lyse these cells. Further development of the approach presented here should allow modification of reoviruses to enhance tumor cell 6 -modified s1 using the anti-His tag serum. T3D depicts a lysate of the unmodified reovirus T3D. Sel9-11 represent T3D reovirus lysates propagated for 9-11 passages on U118scFvHis cells. Loading controls using the antibody 7F4 against reovirus l2 are depicted in the upper panel. (His) 6 -tagged s1 detected with Penta-His antibody is shown in the lower panel. TTELSTLTLRVTSIQADFESRITTLERTAVTSAGAPLSIRNNRMTMGLNDGLTLSGNNLAIRLPGNTGLN  TTELSTLTLRVTSIQADFESRISTLERTAVTSAGAPLSIRNNRMTMGLNDGLTLSGNNLAIRLPGNTGLN  TTELSTLTLRVTSIQADFESRISTLERTAVTSAGAPLSIRNNRMTMGLNDGLTLSGNNLAIRLPGNTGLN  TTELSTLTLRVTSIQADFESRISTLERTAVTSAGAPLSIRNNRMTMGLNDGLTLSGNNLAIRLPGNTGLN  TTELSTLTLRVTSIQADFESRISTLERTAVTSAGAPLSIRNNRMTMGLNDGLTLSGNNLAIRLPGNTGLN  TTELSTLTLRVTSMQADFESRISTLERTAVTSAGAPLSIRNNRMTMGLNGGLTLSGNNLAIRLPGNTGLN  TTELSTLTLRVTSIQADFESRISTLERTAVTSAGAPLSIRNNRMTMGLNDGLTLSGNNLAIRLPGNTGLN   IQNGGLQFRFNTDQFQIVNNNLTLKTTVFDSINSRIGATEQSYVASAVTPLRLNSSTKVLDMLIDSSTLE  IQNGGLQFRFNTDQFQIVNNNLTLKTTVFDSINSRIGATEQSYVASAVTPLRLNSSTKVLDMLIDSSTLE  IQNGGLQFRFNTDQFQIVNNNLTLKTTVFDSINSRTGAIEQSYVASAVTPLRLNSSTKVLDMLIDSSTLE  IQNGGLQFRFNTDQFQIVNNNLTLKTTVFDSINSRTGAIEQSYVASAVTPLRLNSSTKVLDMLIDSSTLE  IQNGGLQFRFNTDQFQIVNNNLTLKTTVFDSINSRTGAIEQSYVASAVTPLRLNSSTKVLDMLIDSSTLE  IQNGGLQFRFNTDQFQIVNNNLTLKTTVFDSINSRTGAIEQSYVASAVTPLRLNSSTKVLDMLIDSSTLE  IQNGGLQFRFNTDQFQIVNNNLTLKTTVFDSINSRTGAIEQSYVASAVTPLRLNSSTKVLDMLIDSSTLE   INSSGQLTVRSTSPNLRYPIADVSGGIGMSPNYRFRQSMWIGIVSYSGSGLNWRVQVNSDIFIVDDYIHI  INSSGQLTVRSTSPNLRYPIADVSGGIGMSPNYRFRQSMWIGIVSYSGSGLNWRVQVNSDIFIVDDYIHI  INSSGQLTVRSTSPNLRYPIADVSGGIGMSPNYRFRQSMWIGIVSYSGSGLNWRVQVNSDIFIVDDYIHI  INSSGQLTVRSTSPNLRYPIADVSGGIGMSPNYRFRQSMWIGIVYYSGSGLNWRVQVNSDIFIVDDYIHI  INSSGQLTVRSTSPNLRYPIADVSGGIGMSPNYRFRQSMWIGIVYYSGSGLNWRVQVNSDIFIVDDYIHI  INSSGQLTVRSTSPNLRYPIADVSGGIGMSPNYRFRQSMWIGIVYYSGSGLNWRVQVNSDIFIVDDYIHI  INSSGQLTVRSTSPNLRYPIADVSAGIGMSPNYRFRQSMWIGIVYYSGSGLNWRVQVNSDIFIVDDYIHI   CLPAFDGFSIADGGDLSLNFVTGLLPPLLTGDTEPAFHNDVVTYGAQTVAIGLSSGGAPQYMSKNLWVEQ  CLPAFDGFSIADGGDLSLNFVTGLLPPLLTGDTEPAFHNDVVTYGAQTVAIGLSSGGAPQYMSKNLWVEQ  CLPAFDGFSIADGGDLSLNFVTGLLPPLLTGDTEPAFHNDVVTYGAQTVAIGLSSGGAPQYMSKNLWVEQ  CLPAFDGFSIADGGDLSLNFVTGLLPPLLTGDTEPAFHNDVVTYGAQTVAIGLSSGGAPQYMSKNLWVEQ  CLPAFDGFSIADGGDLSLNFVTGLLPPLLTGDTEPAFHNDVVTYGAQTVAIGLSSGGAPQYMSKNLWVEQ  CLPAFDGFSIADGGDLSLNFVTGLLPPLLTGDTEPAFHNDVVTYGAQTVAIGLSSGGAPQYMSKNLWVEQ  CLPAFDGFSIADGGDLSLNFVTGLLPPLLTGDTEPAFHNDVVTYGAQTVAIGLSSGGAPQYMSKNLWVEQ WQDGVLRLRVEGGGSITHSNSKWPAMTVSYPRSFT------WQDGVLRLRVEGGGSITHSNSKWPAMTVSYPRSFT------WQDGVLRLRVEGGGSITHSNSKWPAMTVSYPRSFTHHHHHH WQDGVLRLRVEGGGSITHSNSKWPAMTVSYPRSFTHHHHHH WQDGVLRLRVEGGGSITHSNSKWPAMTVSYPRSFTHHHHHH WQDGVLRLRVEGGGSITHSNSKWPAMTVSYPRSFTHHHHHH WQDGVLRLRVEGGGSITHSNSKWPAMTVSYPRSFTHHHHHH Figure 7 Amino-acid sequence of different s1 and s1-His proteins. The amino-acid sequence alignment of s1 (455 aa) and s1-His (461 aa) is shown. The upper sequence (s1 [pub] ) is the published sequence of s1 (accession number gi|333742|gb|M10262.1). R124 is our lab strain of reovirus T3D. The isolate was purified from the VR-824 stock obtained from the ATCC by two rounds of plaque purification on 911 cells. s1-His (cloned) is the sequence in pRT3S1His. s1-His RT1 and -2 are two RT-PCR-amplified clones from the ATCC-T3D-derived T3D-S1His viruses. s1-His RT3 and -4 are amplified clones from the R124-S1His virus. The amino-acid changes are color-coded. RT-PCR, reverse transcription-PCR.
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transduction and reduce the infection of non-target cells. This will increase the safety and efficacy of anticancer strategies using reoviruses as oncolytic agents. We have developed a simple technique to genetically modify reoviruses and identified the C terminus of s1 as a good location for insertion of targeting oligopeptides. Moreover, the (His) 6 tag at the C terminus of s1, in combination with the U118scFvHis cells, allowed the construction of reoviruses that do not depend on JAM-1 for attachment and cell entry. Furthermore, the development of tumor-targeted reoviruses can benefit from the experience with targeted adenoviruses, especially as the spatial structure of the reovirus spike is remarkably similar to that of the adenovirus fiber. 42 The reovirus genetic modification technique developed in this study may be widely applicable. It may be adapted for other reovirus genome segments. 43 This would allow the generation of defined mutants for gaining insight into the intricate interactions between the reoviruses and their hosts, and also address questions about virus structure, function and pathogenesis. The strategy may be amendable for use in other Reoviridae. Although from the family name one may get the impression that all its members are 'orphan' viruses, some of them cause severe diseases and have considerable economic impact. Members of its genera Orbivirus and Coltivirus cause diseases in humans, for example Colorado tick fever, and in domestic livestock, for Figure 8 Selection of R124-S1His reoviruses on U118scFvHis cells. (a) The s1-His protein is present in lysates of R124-S1His reoviruses serially passaged on U118scFvHis cells. R124 is a lysate of the plaque-purified T3D reovirus. Sel4-6 depict R124-S1His reovirus lysates isolated after the indicated number of passages on U118scFvHis cells. Upper panel: western blot analysis for l2. The presence of l2 was confirmed by western blotting using the 7F4 specific for l2. Lower panel: western blotting demonstrates the presence of (His) 6 -tagged s1 with the Penta-His antibody in the R124-S1His virus. (b) Nucleotide differences distinguish the cloned S1His sequence and the R124 S1 sequence. The amino acids coded by codons at positions 749 and 758 of the R124-S1 create a trypsin-cleavable site in s1 ( ). (c) Sequence analyses depict the differences at nucleotides 747-760 of RT-PCR clone R124-S1His RT4 and R124. Arrows represent the nucleotide differences at positions 749 and 758. (d) The R124-S1His reovirus specifically eradicates the U118scFvHis cells from a mixed population. A mixture of U118scFvHis and U118-eGFP cells were infected with R124-S1His reovirus at an MOI of 2, and samples were taken for flow-cytometric analyses at the indicated times after the infection. Represented is the relative frequency of GFP-positive cells in the virus-infected cultures relative to mock-infected cultures. These data show that the relative frequency of the R124-S1His-resistant eGFP-positive cells increased more than 10-fold on selective eradication of the cells that are sensitive to the targeted reovirus. GFP, green fluorescent protein; MOI, multiplicity of infection; RT-PCR, reverse transcription-PCR.
example African horse sickness and blue-tongue disease. 44 Moreover, members of the genus Rotaviruses are the major etiologic agents of serious diarrhea in children under 2 years of age. 45 In these genera, too, this reverse genetics technique may be very useful.
Materials and methods
Cell lines
The cell line 911 is adenovirus type 5 early region 1-transformed human embryonic retinoblast. 46 U118MG human glioblastoma cells were obtained from Dr B de Leeuw (Erasmus Medical Center, Rotterdam, The Netherlands). All cell lines were cultured in Dulbecco's modified Eagle's medium (Invitrogen, Breda, The Netherlands) supplemented with penicillin, streptomycin, glucose and 8% fetal bovine serum (Invitrogen), unless otherwise specified. Cells were cultured in a 5% CO 2 atmosphere at 37 1C.
Reovirus propagation
The cell line 911 was used to propagate wild-type T3D (American Type Culture Collection, VR-824) as described previously. 47 Briefly, the cells were exposed to reovirus in Dulbecco's modified Eagle's medium/2% fetal bovine serum for 2 h at 37 1C, 5% CO 2 . Subsequently, the inoculum was replaced by Dulbecco's modified Eagle's medium containing 8% fetal bovine serum. The virus was harvested 48 h postinfection by resuspending the cells in phosphate-buffered saline with 2% fetal bovine serum and subjecting the suspension to three cycles of freezing and thawing. The sample was cleared by centrifugation for 10 min at 800 g. Where indicated, the virus was further purified by CsCl equilibrium centrifugation essentially as described. 46 In some experiments, the R124 clonal isolate was used. This isolate was purified from the VR-824 stock obtained from the ATCC by two rounds of plaque purification on 911 cells. The infectious reovirus titer was determined by plaque assay on 911 cells.
Cell viability assay
WST-1 reagent (Roche, Woerden, The Netherlands) was used to assay the viability of cells after reovirus infections. Cells were infected with different amounts of reovirus in 96-well plates and WST-1 reagent was added, according to the manufacturer's instructions, at various time points postinfection.
Cloning of T3D S1 from infected 911 cells
Cultures of 911 cells were infected with wild-type reovirus T3D at an MOI of B2 plaque-forming units (PFU) per cell. Total cellular RNA was extracted 24 h postinfection using the Absolutely RNA miniprep kit (Stratagene, Huissen, The Netherlands). First-strand cDNA synthesis employed the ReoS1 Rev primer, using SuperScript II reverse transcriptase (Invitrogen). Pfu polymerase (Promega, Leiden, The Netherlands) was used for template amplification. See Table 1 for details about the primers and the PCR fragments. The PCR product was purified from a 1% agarose gel using the JetSorb kit (Genomed, ITK Diagnostics, Uithoorn, The Netherlands). The product was digested using HindIII and NotI, and cloned into the plasmid pCDNA3.1+ (Invitrogen) digested with the same enzymes, yielding plasmid pRT3S1. The sequence of the insert was verified at the Leiden Genome Technology Center.
To insert the codons for the (His) 6 tag at the C terminus of s1, the s1-coding region was PCR-amplified with primers HisReoS1_Rev and ReoS1_For (Table 1) . The PCR product was digested with HindIII and ligated to HindIII-and EcoRV-digested pCDNA3.1+. The resulting plasmid was used as template for PCR amplification with primers SigmaEnd_Rev and ReoS1_For and, after digestion with HindIII, ligated into HindIII-and EcoRVdigested plasmid pCDNA3.1+, generating plasmid pRT3S1His.
The sequences of all the constructs described in this study are available on request.
Reverse transcription-PCR
Primers used for the RT-PCR procedures are listed in Table 1 . For the detection of human JAM-1 RNA, 911 cells and U118MG cells were seeded on 5 cm dishes and total cellular RNA was isolated using the Absolutely RNA miniprep kit (Stratagene). In all cases, SuperScript II was used to generate first-strand cDNA. For the characterization of the 911S1His cell line, total cellular RNA was extracted from confluent cultures of 911 and 911S1His cells, as described above. For the detection of S1His in reovirus batches, infections of 911 cells were performed. RNA was isolated 24 h after infection and used for RT-PCR amplification. The resulting PCR products were cloned into plasmid pTOPO-TA (Invitrogen) and their DNA sequences were determined.
Production of lentiviral vectors
All lentiviral constructs used in this study were based on the pLV-CMV-x-IRES-Neo vector 48 (see Figure 3) . The S1His region of plasmid pRT3S1His was released by Eco105I and XbaI digestion and inserted into the same restriction sites of pLV-CMV-x-IRES-Neo. To generate the HA-JAM lentiviral expression vector, plasmid pCDNA-HA-JAM 49 (kindly provided by Dr UP Naik, Delaware, Newark) was digested with Eco105I and XbaI and inserted into pLV-CMV-BC-Neo. Plasmid pLV-JAM-ECD-IRES-Neo was made by first inserting the codons for the ECD of JAM into pDisplay (Invitrogen) and cloning the Eco105I-XhoI fragment into the same sites of the pLV vector. pCDNA-HA-JAM was used as template to amplify the JAM-ECD (see Table 1 ). To generate pLVscFvHis-IRES-Neo, encoding the anti-His tag singlechain antibody fragment, pHissFv.rec 32 (a kind gift from Dr DT Curiel, University of Alabama) was digested with Eco105I and XhoI and inserted into the pLV vector. Production of the lentiviral vectors and transduction of the cells were performed as described previously. 48, 50 The LV-S1His vector was used for transducing cultures of 911 cells at an estimated MOI of 0.5. The polyclonal G418-resistant cell population, referred to as 911S1His cells, were used for further studies.
Generation of modified reoviruses carrying the S1His segment
Wild-type reoviruses were used to infect 911S1His cells according to routine procedures. After three rounds of propagation, the resulting s1-His-containing viruses were harvested by freeze thawing and used to infect À1 ; Amersham, Roosendaal, The Netherlands) for 4 h at various time points postinfection. Cells were washed once with phosphate-buffered saline and lysed in Giordano Lysis Buffer (50 mM Tris-Cl (pH ¼ 7.4), 250 mM NaCl, 0.1% Triton, 5 mM EDTA) containing protease inhibitors (Complete mini tablets, Roche Diagnostics, Almere, The Netherlands). All labeling assays were performed in 24-well plates with 5 ml Pro-mix per well. The cells were lysed with 100 ml lysis buffer per well. Fifty microliters of the lysates was loaded on a 10% SDS-polyacrylamide gel after addition of sample buffer. Gels were dried and exposed to a radiographic film to visualize the labeled proteins.
Immunofluorescence assay
For immunofluorescence assays, cells were grown on round glass coverslips in 24-well plates, fixed with methanol, washed with phosphate-buffered saline containing 0.05% Tween 20 and incubated with a primary antibody against the oligo (His) tag primary antibody (Sigma Aldrich, Zwijndrecht, The Netherlands). The coverslips were washed and incubated with secondary fluorescein isothiocyanate-conjugated goat anti-mouse serum for 30 min at room temperature. The mounting solution consisted of glycerol containing 0.02 M Tris-HCl (pH ¼ 8.0), 2.3% 1,4-diazabicyclo-[2.2.2]-octane and 0.5 mg ml À1 4 0 ,6-diamidino-2-phenylindole to visualize the nuclei.
Western blot analysis
Cell lysates were made in Giordano lysis buffer (50 mM Tris-HCl pH 7.4, 250 mM NaCl, 0.1% Triton, 5 mM EDTA) supplemented with protease inhibitors. Reovirus lysates were prepared by adding 15 ml of cleared reovirus to 5 ml of western sample buffer (final concentrations: 10% glycerol, 2% SDS, 60 mM Tris-Cl (pH 6.7), 2.5% b-mercaptoethanol and 2.5% bromophenol blue). After incubation for 3 min at 100 1C, the samples were analyzed on SDS 10% polyacrylamide gels. The proteins were transferred to Immobilon-P (Millipore, Etten-Leur, The Netherlands) and visualized using standard protocols. Primary antibodies used were the Penta-His antibody (Qiagen, Venlo, The Netherlands) for detection of the (His) 6 tag and 7F4 directed against reovirus protein l2 51 (kindly provided by Dr K Tyler, University of Colorado Health Science Center, Denver, Colorado). The secondary antibody used was horseradish peroxidaseconjugated Goat anti-Mouse IgG (Santa Cruz Biotechnology, Santa Cruz, CA, USA).
Selective eradication assay
U118MG cells were transduced with a lentiviral vector encoding the eGFP gene. 50 . The resulting U118eGFP cells were mixed with U118scFvHis cells and seeded in sixwell plates. The mixed cultures were either mockinfected or infected with R124-S1His (MOI of B1 PFU per cell). At the indicated time points after the infection, the cocultures were trypsinized and the cells collected in phosphate-buffered saline. These cell suspensions were analyzed for eGFP activity using a BD LSRII flow cytometer and BD FACSDiva software (BD Bioscience, Breda, The Netherlands).
